2008
DOI: 10.4321/s1130-01082008001200006
|View full text |Cite
|
Sign up to set email alerts
|

Interleucina-18 (IL-18) y otros parámetros inmunológicos como marcadores de gravedad en la pancreatitis aguda

Abstract: A pesar de que en la actualidad poseemos conocimientos más profundos sobre la fisiopatología de la pancreatitis aguda (PA), y que disponemos de mejores medios terapéuticos fundamentalmente a nivel de cuidados intensivos, sin embargo se mantiene una elevada morbili- RESUMENObjetivo: se trata de comparar prospectivamente el comportamiento durante la primera semana del ingreso de los niveles de interleucina-18 (IL-18), y otros parámetros inmunológicos entre pacientes con pancreatitis aguda con y sin criterios de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
3
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 38 publications
0
3
0
1
Order By: Relevance
“…On the other hand, Martin et al . compared IL-18 levels in patients suffering from AP with those in patients with cholecystolithiasis or common bile duct lithiasis without cholangitis [ 30 ]. Thirty-six patients were included in the study, in whom IL-18 levels were measured on the first, second, third, fifth, and seventh day of the disease.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…On the other hand, Martin et al . compared IL-18 levels in patients suffering from AP with those in patients with cholecystolithiasis or common bile duct lithiasis without cholangitis [ 30 ]. Thirty-six patients were included in the study, in whom IL-18 levels were measured on the first, second, third, fifth, and seventh day of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…A significant difference between patients suffering from both forms of AP existed only during the first 24 h. Martin et al . assumed that IL-18 may be acknowledged as an early marker of both systemic and locoregional complications on account of its larger increase in the severe form of AP [ 30 ]. Both in patients suffering from the benign and the severe form of AP, IL-18 levels measured on the first, third, fifth, and tenth days of the disease were significantly higher than in the control group.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Com isso, nota-se que esta interleucina pode ser preditora da severidade da PA na fase inicial. (120) Os resultados obtidos com esta pesquisa não apresentam diferença estatística entre os grupos provavelmente em decorrência do período escolhido para coleta das amostras.…”
Section: Discussionunclassified